Clinic
Hickory Flat Clinic, LLC
Hickory Flat Clinic, LLC was paid $482K by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 70% of everything it billed.
33Billing provider infoHICKORY FLAT CLINIC, LLC
HICKORY FLAT, MS 38633
HICKORY FLAT, MS 38633
33aNPI1326380189assigned 03/20/2013
33bProvider typeCommunity Health Clinic/Center
28Total paid$482K
24GClaims18,080
24DCodes billed24
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in Mississippi
Rank by total paid#4 of 11
Median peer was paid$284K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,970 | $53K | |
| 2019 | 1,984 | $50K | |
| 2020 | 1,915 | $45K | |
| 2021 | 4,396 | $111K | |
| 2022 | 3,694 | $105K | |
| 2023 | 2,704 | $74K | |
| 2024incomplete | 1,417 | $43K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 70% | 8,031 | 6,354 | $337K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 9.3% | 1,685 | 1,426 | $45K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.3% | 1,034 | 764 | $26K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.5% | 312 | 220 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.4% | 2,032 | 1,664 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.8% | 1,208 | 1,066 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 1,044 | 938 | $11K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 238 | 186 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 102 | 83 | $3K |
| 86328 | <1% | 81 | 70 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 822 | 749 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 62 | 56 | $387.32 |
12 more codes
| 99443 | <1% | 16 | $361.28 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 71 | $336.05 |
| 87807 | <1% | 26 | $242.55 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 126 | $130.90 |
| 92551 | <1% | 13 | $126.57 | |
| 87276 | <1% | 47 | $75.90 | |
| 87275 | <1% | 62 | $75.90 | |
| 90686 | <1% | 25 | $62.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 820 | $57.97 |
| 99173 | <1% | 13 | $35.97 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 31 | $17.10 |
| J0945 | Injection, brompheniramine maleate, per 10 mg | <1% | 179 | $2.55 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMPSON, STEPHANIE (FNP)